CLINICAL VALUE OF CHROMOGRANIN A IN GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS

CLINICAL VALUE OF CHROMOGRANIN A IN GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS

Background: Neuroendocrine tumors (NET) is a heterogeneous group of neoplasms characterized by hypersecretion of biologically active sub- stances that manifests by specific syndromes and determines the clinical course of the disease. The most common NET types are those of gastrointestinal tract. The...

Full description

Bibliographic Details
Main Authors:	N. V. Lyubimova, M. G. Toms, T. K. Churikova, T. Yu. Kharitid
Format:	Article
Language:	Russian
Published:	MONIKI 2016-02-01
Series:	Alʹmanah Kliničeskoj Mediciny
Subjects:	chromogranin a biochemical marker neuroendocrine tumors diagnostics
Online Access:	https://www.almclinmed.ru/jour/article/view/75

Similar Items

Chromogranin A and serotonin for evaluation of treatment efficacy of neuroendocrine tumors
by: N. V. Lyubimova, et al.
Published: (2020-01-01)

The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience
by: Hui-Jen Tsai, et al.
Published: (2021-11-01)

Chromogranin A as a Biochemical Marker for Neuroendocrine Tumors: A Single Center Experience at Royal Hospital, Oman
by: Elham S. Al-Risi, et al.
Published: (2017-09-01)

Serum Chromogranin Level in Gastrointestinal, Pancreas, and Liver Neuroendocrine Tumors: A Brief Report
by: Mahboubeh Azema, et al.
Published: (2022-01-01)

Analytical aspects of gastrin measurement in neuroendocrine tumors
by: N. V. Lyubimova, et al.
Published: (2018-08-01)

Chromogranin A: As A Tumor Marker for Neuroendocrine Tumors Diagnosis, Follow-up & Its Correlation with Response to Somatostatin Analogues
by: Manwar A. Mohammed AL-Naqqash
Published: (2016-01-01)

Prognostic significance of dynamics of biochemical markers of neuroendocrine tumors during treatment with biotherapy
by: G S Emelianova, et al.
Published: (2014-06-01)

Significance of chromogranin A and synaptophysin in pancreatic neuroendocrine tumors
by: Tatsuo Tomita
Published: (2020-08-01)

Chromogranin A as Serum Marker for Gastroenteropancreatic Neuroendocrine Tumors: A Single Center Experience and Literature Review
by: Christoph J. Auernhammer, et al.
Published: (2012-02-01)

P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms
by: Kirstine Nielsen, et al.
Published: (2020-01-01)

Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors
by: Jonas Baekdal, et al.
Published: (2020-10-01)

Neuroendocrine tumors: Laboratory diagnosis
by: Tzontcheva Anna
Published: (2010-01-01)

Performance Evaluation of the KRYPTOR Compact PLUS Analyzer-Based B.R.A.H.M.S. CgA Ⅱ KRYPTOR Assay for Chromogranin A Measurement
by: Yu Jeong Choi, et al.
Published: (2021-12-01)

Bone metastases from neuroendocrine tumors: clinical and biological considerations
by: Matteo Scopel, et al.
Published: (2022-06-01)

BIOCHEMICAL MARKERS IN SERUM AND URINE IN THE WORKUP OF PATIENTS WITH NEUROENDOCRINE TUMORS
by: N. V. Lyubimova, et al.
Published: (2016-12-01)

Predictors of Outcomes in Gastric Neuroendocrine Tumors: A Retrospective Cohort
by: Raquel Ortigão, et al.
Published: (2023-07-01)

Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future
by: Paweł Komarnicki, et al.
Published: (2022-09-01)

A rare case of prostate neuroendocrine tumor: A case report
by: Shunxing Teh, et al.
Published: (2022-10-01)

Comparison of PCR-based detection of chromogranin A mRNA with traditional histological lymph node staging of small intestinal neuroendocrine neoplasia
by: Lawrence Ben, et al.
Published: (2012-06-01)

Diagnostic work-up and advancement in the diagnosis of gastroenteropancreatic neuroendocrine neoplasms
by: Apostolos Koffas, et al.
Published: (2023-03-01)

Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors
by: Andrea Sansone, et al.
Published: (2019-08-01)

Prognostic value of chromogranin A in patients with GET/NEN in the pancreas and the small intestine
by: Małgorzata Fuksiewicz, et al.
Published: (2018-06-01)

Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse Prognosis
by: Zoltan Herold, et al.
Published: (2020-12-01)

Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors
by: Kjell Öberg
Published: (2012-01-01)

The Clinico-epidemiologic Characteristics of Iraqi Patients with Neuroendocrine Tumors and Their Response to Long Acting Octreotide
by: Marwah K. Abdulfattah, et al.
Published: (2016-01-01)

Cystic Pancreatic Neuroendocrine Tumor: A Diagnostic Dilemma
by: Md Ali Osama, et al.
Published: (2023-03-01)

Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy
by: Judy S. Crabtree
Published: (2017-12-01)

Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors
by: Mauro Cives, et al.
Published: (2020-11-01)

Editorial: Neuroendocrine tumors of the gastrointestinal tract, liver, and pancreas: current management and treatment strategies
by: Alexandros Giakoustidis, et al.
Published: (2023-05-01)

Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study
by: Mark J. C. van Treijen, et al.
Published: (2018-12-01)

CROMOGRANIN A AND ITS CLINICAL USE
by: Rudi Pavlin
Published: (2003-09-01)

Medical Treatment of Gastroenteropancreatic Neuroendocrine Tumors
by: Thomas Gress, et al.
Published: (2012-02-01)

Correlation between expression of immunohistochemical markers and morphology in lung neuroendocrine neoplasms
by: Halyna Chytaieva, et al.
Published: (2022-03-01)

Clinicopathologic Features of Gastroenteropancreatic Neuroendocrine Tumors: A Single-center Experience
by: Tuğba Akın Telli, et al.
Published: (2020-09-01)

The neuroendocrine markers assay and the glycemia profile in patients with neuroendocrine tumors under octreotide therapy: a 2 years study / Determinarea markerilor neuroendocrini şi a profilului glicemic la pacienţii cu tumori neuroendocrine în tratament cu octreotid
by: Poiană Cătălina, et al.
Published: (2014-09-01)

Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm
by: Huiying Shi, et al.
Published: (2020-09-01)

Chromogranin A: An Endocrine Factor of Pregnancy
by: Michalina Bralewska, et al.
Published: (2023-03-01)

Neuroendocrine Tumors: Genomics and Molecular Biomarkers with a Focus on Metastatic Disease
by: Erica S. Alexander, et al.
Published: (2023-04-01)

Therapy Resistant Gastroenteropancreatic Neuroendocrine Tumors
by: Kristen McClellan, et al.
Published: (2022-09-01)

Liver transplantation in gastroenteropancreatic neuroendocrine tumors
by: Eduardo de Souza M. Fernandes, et al.
Published: (2023-02-01)